GSA CAPITAL PARTNERS LLP - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 143 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2018$85,000
-86.8%
14,000
-79.2%
0.00%
-89.7%
Q4 2017$646,000
+95.8%
67,200
+80.6%
0.04%
+77.3%
Q3 2017$330,000
-46.3%
37,200
-23.5%
0.02%
-45.0%
Q2 2017$615,000
-27.7%
48,600
-40.0%
0.04%
-13.0%
Q1 2017$851,000
+97.9%
81,000
+73.4%
0.05%
+76.9%
Q4 2016$430,000
-60.7%
46,700
-49.7%
0.03%
-55.9%
Q3 2016$1,095,000
-27.8%
92,900
-2.1%
0.06%
-39.2%
Q1 2016$1,517,000
-76.6%
94,878
-58.2%
0.10%
-69.5%
Q4 2015$6,491,000
+730.1%
226,712
+725.6%
0.32%
+736.8%
Q3 2015$782,000
-26.1%
27,460
-6.8%
0.04%
-7.3%
Q2 2015$1,058,000
+23.2%
29,460
+99.3%
0.04%
+20.6%
Q1 2015$859,00014,7850.03%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2016
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders